NSE › Healthcare

Morepen Laboratories Limited (MOREPENLAB)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹57.65+7.16%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹485 cr
Revenue YoY
+3.0%
Net profit
₹16 cr
Profit YoY
-22.5%
EPS
₹0.16
EPS estimate
₹0.17
Net margin
3.2%

EPS came in at 0.16 against a street estimate of 0.17 — a miss of 5.9%.

Key statistics

Market cap
₹3,116 cr
P/E
32.9
Forward P/E
0.0
P/B
2.51
Book value
₹22.17
EPS (TTM)
₹1.73
Dividend yield
0.35%
52-week high
₹64.58
52-week low
₹33.05
50-day MA
₹53.19
200-day MA
₹44.05
Beta
0.70

Shareholding

Promoters
42.69%
Institutions
1.36%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Morepen Laboratories Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.